Literature DB >> 12697812

Transmodulation between phospholipase D and c-Src enhances cell proliferation.

Bong-Hyun Ahn1, Shi Yeon Kim, Eun Hee Kim, Kyeong Sook Choi, Taeg Kyu Kwon, Young Han Lee, Jong-Soo Chang, Myung-Suk Kim, Yang-Hyeok Jo, Do Sik Min.   

Abstract

Phospholipase D (PLD) has been implicated in the signal transduction pathways initiated by several mitogenic protein tyrosine kinases. We demonstrate for the first time that most notably PLD2 and to a lesser extent the PLD1 isoform are tyrosine phosphorylated by c-Src tyrosine kinase via direct association. Moreover, epidermal growth factor induced tyrosine phosphorylation of PLD2 and its interaction with c-Src in A431 cells. Interaction between these proteins is via the pleckstrin homology domain of PLD2 and the catalytic domain of c-Src. Coexpression of PLD1 or PLD2 with c-Src synergistically enhances cellular proliferation compared with expression of either molecule. While PLD activity as a lipid-hydrolyzing enzyme is not affected by c-Src, wild-type PLDs but not catalytically inactive PLD mutants significantly increase c-Src kinase activity, up-regulating c-Src-mediated paxillin phosphorylation and extracellular signal-regulated kinase activity. These results demonstrate the critical role of PLD catalytic activity in the stimulation of Src signaling. In conclusion, we provide the first evidence that c-Src acts as a kinase of PLD and PLD acts as an activator of c-Src. This transmodulation between c-Src and PLD may contribute to the promotion of cellular proliferation via amplification of mitogenic signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697812      PMCID: PMC153190          DOI: 10.1128/MCB.23.9.3103-3115.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Phospholipase D activation by norepinephrine is mediated by 12(s)-, 15(s)-, and 20-hydroxyeicosatetraenoic acids generated by stimulation of cytosolic phospholipase a2. tyrosine phosphorylation of phospholipase d2 in response to norepinephrine.

Authors:  J H Parmentier; M M Muthalif; A E Saeed; K U Malik
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

2.  Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells.

Authors:  V Natarajan; W M Scribner; A J Morris; S Roy; S Vepa; J Yang; R Wadgaonkar; S P Reddy; J G Garcia; N L Parinandi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-08       Impact factor: 5.464

3.  Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2.

Authors:  T Joseph; R Wooden; A Bryant; M Zhong; Z Lu; D A Foster
Journal:  Biochem Biophys Res Commun       Date:  2001-12-21       Impact factor: 3.575

4.  c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic. Role in carcinogenesis.

Authors:  Petia P Simeonova; Shiyi Wang; Tracy Hulderman; Michael I Luster
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

Review 5.  The Phox homology (PX) domain, a new player in phosphoinositide signalling.

Authors:  Y Xu; L F Seet; B Hanson; W Hong
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

6.  Crystal structures of c-Src reveal features of its autoinhibitory mechanism.

Authors:  W Xu; A Doshi; M Lei; M J Eck; S C Harrison
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

7.  Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells.

Authors:  D S Min; B H Ahn; D J Rhie; S H Yoon; S J Hahn; M S Kim; Y H Jo
Journal:  Neuropharmacology       Date:  2001-09       Impact factor: 5.250

8.  Differential tyrosine phosphorylation of phospholipase D isozymes by hydrogen peroxide and the epidermal growth factor in A431 epidermoid carcinoma cells.

Authors:  D S Min; B H Ahn; Y H Jo
Journal:  Mol Cells       Date:  2001-06-30       Impact factor: 5.034

9.  Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.

Authors:  D S Min; T K Kwon; W S Park; J S Chang; S K Park; B H Ahn; Z Y Ryoo; Y H Lee; Y S Lee; D J Rhie; S H Yoon; S J Hahn; M S Kim; Y H Jo
Journal:  Carcinogenesis       Date:  2001-10       Impact factor: 4.944

Review 10.  Intracellular signaling by phospholipase D as a therapeutic target.

Authors:  P M Steed; A H Chow
Journal:  Curr Pharm Biotechnol       Date:  2001-09       Impact factor: 2.837

View more
  36 in total

Review 1.  Rethinking the role of Src family protein tyrosine kinases in the allergic response: new insights on the functional coupling of the high affinity IgE receptor.

Authors:  Yasuko Furumoto; Claudia Gonzalez-Espinosa; Gregorio Gomez; Martina Kovarova; Sandra Odom; Valentino Parravicini; John J Ryana; Juan Rivera
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.

Authors:  Katie Knapek; Kathleen Frondorf; Jennalee Post; Stephen Short; Dianne Cox; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

3.  A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.

Authors:  Karen M Henkels; Hong-Juan Peng; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 4.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

Review 5.  Phospholipase D and phosphatidic acid in the biogenesis and cargo loading of extracellular vesicles.

Authors:  Antonio Luis Egea-Jimenez; Pascale Zimmermann
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

Review 6.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 7.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

8.  Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.

Authors:  Dong Woo Kang; Gyesik Min; Do Yoon Park; Ki Whan Hong; Do Sik Min
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

Review 9.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

10.  Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.

Authors:  Dong Woo Kang; Do Sik Min
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.